Konan Medical USA, Inc. recently announced it has entered into an exclusive agreement with Chart2020, a provider of visual acuity and ocular performance testing software. Konan will develop, market, and distribute Chart2020 globally.
Irvine, CA-Konan Medical USA, Inc. recently announced it has entered into an exclusive agreement with Chart2020, a provider of visual acuity and ocular performance testing software. Konan will develop, market, and distribute Chart2020 globally.
Chart2020 v5 is an vision testing software platform with a redesigned user experience that can be controlled with the Chart2020 Duo app for iPad. The iPad can also be used to administer a number of guided, self-scoring tests including ColorDx, Konan’s new color vision testing software.
Central to Chart2020’s innovative user experience are SmartDocks, which enable users to quickly and easily access test libraries, sequences, system settings and Konan Wizards, a suite of guided, self-scoring tests. Examples of Wizards include stereo acuity, contrast sensitivity and ColorDx color vision diagnostics. Additionally, Chart2020 features global Sloan compliant optotypes for non-Western languages including Japanese, Korean, Russian, and Arabic, as well as Konan Kids, an optotype designed for children and illiterate adults.
